An 81-year-old man, resident in Yiyang for many years.
She has a history of prostate cancer and coronary heart disease.
She has been living with her elder daughter since she came back from Wuhan and has not left since then.
On February 21st, she suffered a convulsive dry cough and anorexia.
At first, no treatment was given.
On February 25, symptoms worsened with fever (38.0Â°C) and dyspnea.
Tests for influenza A and B were negative.
A chest CT scan showed abnormalities with ground glass opacities.
Symptoms did not improve even after treatment with piperacillin/tailomethasone (4.5 g every 48 h), ambroxol, ribavirin (500 mg every 12 h) and oseltamivir (75 mg twice daily).
On February 27, the nucleic acid test of SARS-CoV-2 was positive, both from nasopharyngeal smears and sputum.
His hemoglobin (83 g/L) and lymphocytes (0.65 * 10^9/L) were below normal levels, while the 26 were above normal levels (5h46 mg/mL), C-reactive protein SG34mg (C-reactive).
Her arterial gas showed a PO2 of 67 mmHg and an FiO2 of 33%.
As a consequence, severe COVID-19 was diagnosed and admitted to the intensive care unit with oxygen, interferon, lopinavir/ritonavir and ribavirin as antiviral treatment, linezolid, steroid-gammaglobulin* and steroid-improvement therapy (MBG200).
On the 2nd and 4th of March, nucleic acid tests were repeated and both were negative.
On March 3, IgM and IgG antibody tests were positive.
A repeat arterial line placement on March 5 showed a PO2 of 114 mmHg and an FiO2 of 33%.
Lung CT showed that inflammatory lesions had been absorbed and that ground glass opacities had improved.
